Akimasa Nakao

A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).

Y. Kodera, M. Fujiwara, A. Nakao, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinical usefulness of CA-19-9 in pancreatic carcinoma.

S. Nomoto, A. Nakao, T. Kaneko, 1998, Seminars in surgical oncology.

Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes

Y. Nishikawa, S. Yamada, T. Fujii, 2012, Cancer Gene Therapy.

Intraoperative diagnosis of pancreatic cancer extension using IVUS.

H. Sugimoto, A. Nakao, T. Kaneko, 2001, Hepato-gastroenterology.

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

S. Yamada, T. Fujii, H. Sugimoto, 2011, Cancer Gene Therapy.

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma

H. Sugimoto, S. Nomoto, S. Takeda, 2007, British Journal of Cancer.

The valine catabolic pathway in human liver: Effect of cirrhosis on enzyme activities

A. Nakao, Y. Shimomura, S. Sugiyama, 1996, Hepatology.

Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.

S. Nomoto, A. Nakao, T. Kaneko, 1999, Hepato-gastroenterology.

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer

Y. Kodera, M. Fujiwara, A. Nakao, 2005, British Journal of Cancer.

Effects of nafamostat mesilate, a synthetic protease inhibitor, on immunity and coagulation after hepatic resection.

J. Sakamoto, A. Nakao, T. Nonami, 1999, Hepato-gastroenterology.